The collaboration between the Swiss pharmaceutical firm Roche and the Denise Nyakeru Tshisekedi Foundation, announced on October 20, 2023, marks a significant step forward in the field of health in the Democratic Republic of Congo (DRC). This partnership aims to strengthen awareness and screening of female cancers, as well as improve access to quality diagnostic equipment and blood collections.
The first part of this collaboration consists of the supply of laboratory equipment to the SS Mixed Medicine and Anemia Center (CMMASS), also known as Mabanga. This center, recently built and rehabilitated, will play an essential role in the fight against diseases and will improve diagnostic capacities in the DRC.
The second part of this partnership aims to increase awareness and screening of women’s cancers, with particular emphasis on breast and cervical cancer. In the DRC, the incidence and mortality linked to these types of cancers are increasing, and early diagnosis remains a major challenge. Thanks to this partnership, awareness-raising actions will be carried out to inform the population about the importance of early detection and to encourage women to be screened regularly.
Finally, this partnership between Roche and the Denise Nyakeru Tshisekedi Foundation will also contribute to improving access to quality blood. Diagnostic equipment will be made available to sickle cell clinics and maternity wards, thus making it possible to meet the growing needs for blood transfusion in the DRC.
The commitment of the First Lady of the DRC, Denise Nyakeru Tshisekedi, to the fight against cancer and the improvement of women’s health is at the heart of this partnership. Its objective is to address the increase in the incidence and mortality of female cancers, by implementing concrete actions to raise awareness among the population and improve access to care.
This partnership between Roche and the Denise Nyakeru Tshisekedi Foundation demonstrates Switzerland’s commitment to the field of health in the DRC. Roche, one of the world leaders in biotechnology and in vitro diagnostics, will put its expertise and resources at the service of the Congolese population to fight diseases and improve the quality of care.
This collaboration also paves the way for future actions in other provinces of the DRC, with the aim of reaching a greater number of people and having a positive impact on the health of the Congolese population.
In conclusion, this partnership between Roche and the Denise Nyakeru Tshisekedi Foundation marks an important step in the fight against female cancers and the improvement of health in the DRC.. By joining forces, these two players are helping to strengthen diagnostic capacities, raise awareness of female cancers and improve access to quality care. An initiative that demonstrates the importance of international cooperation in promoting health and well-being for all.